Herman Weiss
Chairman bei TODOS MEDICAL LTD.
Aktive Positionen von Herman Weiss
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
TODOS MEDICAL LTD. | Chairman | 22.06.2017 | - |
Director/Board Member | 22.06.2017 | 10.01.2020 | |
Chief Executive Officer | 30.07.2018 | 10.01.2020 | |
President | 30.07.2018 | 10.01.2020 |
Karriereverlauf von Herman Weiss
Ehemalige bekannte Positionen von Herman Weiss
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Chief Tech/Sci/R&D Officer | 01.12.2010 | 01.03.2016 |
Yeshiva University | Corporate Officer/Principal | - | - |
Fibro Control Israel Ltd.
Fibro Control Israel Ltd. Medical DistributorsDistribution Services Fibro Control Israel Ltd. develops devices to treat uterine fibroids. Its invasive technology is based on a novel approach that will overcome disadvantages found in other current fibroid treatments. The company was founded in 2008 and is headquartered in Herzeliya, Israel. | Director of Finance/CFO | - | - |
Founder | - | - | |
JUNIPER PHARMACEUTICALS INC | Corporate Officer/Principal | - | - |
Ausbildung von Herman Weiss
George Washington University | Masters Business Admin |
Ramapo College of New Jersey | Undergraduate Degree |
The Ohio State University College of Medicine | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Israel | 4 |
Operativ
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Masters Business Admin | 1 |
Sektoral
Consumer Services | 5 |
Health Technology | 4 |
Distribution Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
TODOS MEDICAL LTD. | Health Technology |
Private Unternehmen | 2 |
---|---|
Catalent JNP, Inc.
Catalent JNP, Inc. Pharmaceuticals: MajorHealth Technology Catalent JNP, Inc. engages in the research and development of drugs and therapeutics. It offers analytical characterization and pre-formulation testing; formulation development; and clinical manufacturing of capsules and tablets. The company was founded in December 1986 and is headquartered in Somerset, NJ. | Health Technology |
Fibro Control Israel Ltd.
Fibro Control Israel Ltd. Medical DistributorsDistribution Services Fibro Control Israel Ltd. develops devices to treat uterine fibroids. Its invasive technology is based on a novel approach that will overcome disadvantages found in other current fibroid treatments. The company was founded in 2008 and is headquartered in Herzeliya, Israel. | Distribution Services |
- Börse
- Insiders
- Herman Weiss
- Erfahrung